Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy
Endpoints
Mon, 04/13/20 - 11:06 am
Tags:
AstraZeneca, Tagrisso, clinical trials, non-small cell lung cancer
AstraZeneca, Merck secure FDA nod for Koselugo to treat paediatric patients with NF1 genetic disorder
Pharmaceutical Business Review
Mon, 04/13/20 - 10:46 am
Tags:
AstraZeneca, Merck, FDA, Koselugo, pediatric, neurofibromatosis
A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca
Endpoints
Thu, 04/9/20 - 10:37 am
Tags:
Circassia, AstraZeneca, COPD
AstraZeneca targets summer start for COVID-19 antibody trial
Fierce Biotech
Wed, 04/8/20 - 10:31 am
Tags:
AstraZeneca, antibodies, clinical trials, COVID-19
GSK, AstraZeneca in talks for joint U.K. COVID-19 diagnostics project: Bloomberg
Fierce Biotech
Tue, 04/7/20 - 10:40 am
Tags:
GSK, AstraZeneca, UK, diagnostics, COVID-19
AstraZeneca on expanding its diabetes research franchise
Pharmaforum
Fri, 04/3/20 - 11:17 am
Tags:
AstraZeneca, diabetes
AstraZeneca's Farxiga Shows 'Overwhelming Efficacy' in Phase III CKD Trial
BioSpace
Mon, 03/30/20 - 08:12 pm
Tags:
AstraZeneca, chronic kidney disease, clinical trials, Farxiga
AstraZeneca's Imfinzi gets FDA nod to target small-cell lung cancer
Reuters
Mon, 03/30/20 - 10:49 am
Tags:
AstraZeneca, FDA, Imfinzi, lung cancer, Small-Cell Lung Cancer
AstraZeneca: pharma needs to lead by example on sustainability
Pharmaforum
Thu, 03/26/20 - 10:13 am
Tags:
AstraZeneca, sustainability, environmental concerns
AstraZeneca forges alliance with digital health firm BrightInsight
Pharmaforum
Wed, 03/25/20 - 11:53 pm
Tags:
AstraZeneca, BrightInsight, digital health, chronic disease
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, clinical trials, HER2-positive non-small cell lung cancer
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Tags:
Silence Therapeutics, AstraZeneca, siRNA, drug development, cardiovascular disease, renal disease, respiratory disease, metabolic disorders
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
Tags:
FDA, regulatory, Bristol-Myers Squibb, ozanimod, Esteve, E-58425, Fabre-Kramer, AstraZeneca, Imfinzi, Astellas, Vesicare, AbbVie, Neurocrine, Orlissa, Sanofi, MenQuadfi, opicapone, Acceleron, Reblozyl
Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease
Fierce Pharma
Thu, 03/12/20 - 10:57 pm
Tags:
Eli Lilly, Boehringer Ingelheim, AstraZeneca, FDA, Jardiance, kidney disease
AstraZeneca and Merck's string of Lynparza successes ends in ovarian cancer
BioPharma Dive
Thu, 03/12/20 - 12:56 pm
Tags:
AstraZeneca, Merck, cediranib, ovarian cancer, clinical trials, Lynparza
Seattle could waltz in where Astra failed
EP Vantage
Fri, 03/6/20 - 10:34 am
Tags:
AstraZeneca, Imfinizi, bladder cancer, Seattle Genetics, clinical trials, Padcev
Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes
Endpoints
Wed, 03/4/20 - 07:55 pm
Tags:
Cinclus Pharma, AstraZeneca, heartburn, linaprazan, Takeda, acid reflux
AstraZeneca's HQ budget balloons to 3 times original forecast
Fierce Biotech
Wed, 03/4/20 - 10:39 am
Tags:
AstraZeneca, headquarters, UK
AZ picks up $350m after selling hypertension drugs
Pharmaforum
Mon, 03/2/20 - 09:35 am
Tags:
AstraZeneca, hypertension, Atnahs Pharma
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
Fierce Pharma
Tue, 02/25/20 - 04:54 pm
Tags:
AstraZeneca, Redhill Biopharma, constipation, Movantik

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.